DE60138371D1 - PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis - Google Patents
PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie PhotoretinitisInfo
- Publication number
- DE60138371D1 DE60138371D1 DE60138371T DE60138371T DE60138371D1 DE 60138371 D1 DE60138371 D1 DE 60138371D1 DE 60138371 T DE60138371 T DE 60138371T DE 60138371 T DE60138371 T DE 60138371T DE 60138371 D1 DE60138371 D1 DE 60138371D1
- Authority
- DE
- Germany
- Prior art keywords
- photoretinitis
- prostaglandine
- treatment
- light radiation
- eye diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000030533 eye disease Diseases 0.000 title 1
- 230000005855 radiation Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19175500P | 2000-03-24 | 2000-03-24 | |
| PCT/JP2001/002307 WO2001070233A2 (en) | 2000-03-24 | 2001-03-23 | Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60138371D1 true DE60138371D1 (de) | 2009-05-28 |
Family
ID=22706808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60138371T Expired - Lifetime DE60138371D1 (de) | 2000-03-24 | 2001-03-23 | PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7129272B2 (https=) |
| EP (1) | EP1267882B1 (https=) |
| JP (1) | JP2003527430A (https=) |
| KR (1) | KR100788226B1 (https=) |
| CN (1) | CN1443070A (https=) |
| AR (1) | AR030275A1 (https=) |
| AT (1) | ATE428429T1 (https=) |
| AU (2) | AU2001239551B8 (https=) |
| CA (1) | CA2403086C (https=) |
| DE (1) | DE60138371D1 (https=) |
| NZ (1) | NZ521464A (https=) |
| TW (1) | TWI284535B (https=) |
| WO (1) | WO2001070233A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1420794B1 (en) | 2001-08-31 | 2017-12-27 | Sucampo AG | Prostaglandin analogs as chloride channel openers |
| CN1605336A (zh) | 2003-10-10 | 2005-04-13 | 中国医学科学院药物研究所 | 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用 |
| US8202909B2 (en) * | 2005-01-27 | 2012-06-19 | Sucampo Ag | Method for treating central nervous system disorders |
| WO2006106915A1 (ja) * | 2005-03-31 | 2006-10-12 | Asahi Glass Company, Limited | プロスタグランジンＦ2α誘導体を有効成分として含む網膜神経細胞保護剤 |
| JPWO2006112313A1 (ja) | 2005-04-13 | 2008-12-11 | 宇部興産株式会社 | インダゾール誘導体を有効成分として含む網膜神経細胞保護剤 |
| EP1803809A3 (en) * | 2005-08-12 | 2007-12-19 | Abgenomics Corporation | Modulation of peroxisome proliferator-activated receptors |
| US8871752B2 (en) | 2008-02-19 | 2014-10-28 | Sucampo Ag | Method for modulating stem cell growth |
| SG193840A1 (en) * | 2008-09-04 | 2013-10-30 | Santen Pharmaceutical Co Ltd | HAIR GROWTH PROMOTING AGENT CONTAINING 15,15-DIFLUOROPROSTAGLANDIN F2a DERIVATIVE AS ACTIVE INGREDIENT |
| US9084815B2 (en) | 2009-09-16 | 2015-07-21 | Sucampo Ag | Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor |
| WO2014159679A1 (en) | 2013-03-12 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using lubiprostone to absorb fluid from the subretinal space |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166174A (en) | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
| CA1322749C (en) | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
| US5221763A (en) | 1987-04-30 | 1993-06-22 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
| DE3850676T2 (de) * | 1987-09-18 | 1994-11-03 | Ueno Seiyaku Oyo Kenkyujo Kk | Hypotensive okulare Mittel. |
| CA2030345C (en) * | 1989-11-22 | 1998-12-08 | Ryuji Ueno | Use of 15-keto-prostaglandin compound for improvement of encephalic function |
| JPH0761944B2 (ja) * | 1989-11-22 | 1995-07-05 | 株式会社アールテック・ウエノ | 脳機能改善処置剤 |
| TW224942B (https=) | 1990-04-04 | 1994-06-11 | Adka Ueno Kk | |
| CA2150287C (en) | 1994-06-03 | 2004-08-10 | Ryuji Ueno | Agent for treating hepato-biliary diseases |
| JP3625946B2 (ja) * | 1995-03-10 | 2005-03-02 | 株式会社アールテック・ウエノ | 視神経障害改善剤 |
| JPH08277222A (ja) * | 1995-04-05 | 1996-10-22 | Green Cross Corp:The | 神経疾患の予防治療剤 |
| JP3964060B2 (ja) * | 1997-10-21 | 2007-08-22 | 独立行政法人科学技術振興機構 | アポトーシス抑制剤 |
| US6087395A (en) | 1997-10-21 | 2000-07-11 | Japan Science And Technology Corporation | Isocarbacyclin derivatives as apoptosis inhibitors |
| JP2000169394A (ja) * | 1998-12-04 | 2000-06-20 | Yoshitomi Pharmaceut Ind Ltd | アポトーシス誘導剤 |
-
2001
- 2001-03-23 TW TW090107002A patent/TWI284535B/zh not_active IP Right Cessation
- 2001-03-23 AR ARP010101368A patent/AR030275A1/es unknown
- 2001-03-23 DE DE60138371T patent/DE60138371D1/de not_active Expired - Lifetime
- 2001-03-23 CA CA2403086A patent/CA2403086C/en not_active Expired - Fee Related
- 2001-03-23 NZ NZ521464A patent/NZ521464A/en not_active IP Right Cessation
- 2001-03-23 AU AU2001239551A patent/AU2001239551B8/en not_active Ceased
- 2001-03-23 JP JP2001568431A patent/JP2003527430A/ja active Pending
- 2001-03-23 AU AU3955101A patent/AU3955101A/xx active Pending
- 2001-03-23 KR KR1020027012410A patent/KR100788226B1/ko not_active Expired - Fee Related
- 2001-03-23 AT AT01914192T patent/ATE428429T1/de not_active IP Right Cessation
- 2001-03-23 CN CN01809737A patent/CN1443070A/zh active Pending
- 2001-03-23 EP EP01914192A patent/EP1267882B1/en not_active Expired - Lifetime
- 2001-03-23 WO PCT/JP2001/002307 patent/WO2001070233A2/en not_active Ceased
- 2001-03-26 US US09/816,655 patent/US7129272B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2403086A1 (en) | 2001-09-27 |
| CA2403086C (en) | 2010-08-17 |
| NZ521464A (en) | 2004-09-24 |
| CN1443070A (zh) | 2003-09-17 |
| TWI284535B (en) | 2007-08-01 |
| WO2001070233A3 (en) | 2002-06-13 |
| KR20020081474A (ko) | 2002-10-26 |
| JP2003527430A (ja) | 2003-09-16 |
| AR030275A1 (es) | 2003-08-20 |
| AU2001239551B2 (en) | 2005-07-21 |
| US7129272B2 (en) | 2006-10-31 |
| EP1267882B1 (en) | 2009-04-15 |
| AU3955101A (en) | 2001-10-03 |
| EP1267882A2 (en) | 2003-01-02 |
| ATE428429T1 (de) | 2009-05-15 |
| WO2001070233A2 (en) | 2001-09-27 |
| AU2001239551B8 (en) | 2005-11-24 |
| US20020025985A1 (en) | 2002-02-28 |
| KR100788226B1 (ko) | 2007-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| IS7215A (is) | Aðferðir til að meðhöndla nýæðarsjúkdóma í augum | |
| ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
| DE60219292D1 (de) | Pyrazolderivate zur behandlung von hiv | |
| DE69903543D1 (de) | Formulierungen zur behandlung von magen-speiseröhren reflux | |
| DE60022916D1 (de) | Reboxetin zur Behandlung von peripheren Neuropathien | |
| ATE417602T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
| FIU20060389U0 (fi) | Luusairauksien hoito | |
| DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
| DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| ATE414512T1 (de) | Kombinationstherapie zur behandlung von krebs | |
| ATE322872T1 (de) | Skleraprothese zur behandlung der weitsichtigkeit und anderer augenkrankheiten | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| DE60138371D1 (de) | PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis | |
| EP1239851A4 (en) | TREATMENT OF HYPERPROLIFERATIVE DISORDERS | |
| DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| DE60200302D1 (de) | Laseraugenbehandlungseinrichtung | |
| DE60223707D1 (de) | Calcium-l-threonat zur behandlung von knochenfrakturen | |
| ATE330596T1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| ATE285764T1 (de) | Rivastigmine zur behandlung von augenerkrankungen | |
| ATE343387T1 (de) | S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |